Brain-on-Chip platform

AxCellerate Technology

Brain-on-Chip innovation into preclinical neuroscience research.

Human-relevant neuroscience

A Brain-on-Chip platform for human-relevant neuroscience

AxCellerate technology was developed to address a critical limitation in preclinical neuroscience: the gap between conventional experimental models and the complexity of human neuronal biology.

Traditional 2D cell cultures and animal models can provide useful information, but they often struggle to reproduce the structure, activity and functional behaviour of human neural systems. This can reduce the predictive value of early-stage research and increase uncertainty in drug development, disease modelling and safety assessment.

AxCellerate’s Brain-on-Chip platform is designed to create a more human-relevant experimental environment. It enables the culture, imaging and electrophysiological recording of three-dimensional neuronal models, supporting the investigation of neuronal activity, compound response, disease mechanisms and target biology.

How it works

How the technology works

The AxCellerate platform integrates biological, technological and analytical capabilities into an advanced in vitro system.

Three-dimensional neuronal models

Human-derived neuronal systems provide a more relevant context to study complex neural mechanisms.

Brain-on-Chip architecture

Microfabricated structures support controlled culture conditions and advanced experimental workflows.

Functional neuronal readouts

Electrophysiological recording capabilities allow researchers to observe neuronal activity and network response.

Glass-based microtechnology

The platform benefits from precision glass microfabrication, supporting transparency, biocompatibility and reduced compound absorption.

Efficient experimental design

The system is designed to work with small amounts of cells and compounds and to support parallel experimental workflows.

Scientific foundation

From EUROSTARS NEUROCHIP to B2B research services

AxCellerate technology originated from the EUROSTARS NEUROCHIP project, a European research initiative focused on developing a novel Brain-on-Chip model for neurological drug development.

01

European research initiative

The project combined expertise in precision glass microfabrication, microelectrode systems, neuroscience and innovative in vitro assays.

02

Platform development

This scientific foundation led to the development of a platform designed to bring advanced Brain-on-Chip capabilities closer to real preclinical research needs.

03

Applied B2B services

Today, AxCellerate translates this technological foundation into B2B services for organizations working in neuroscience drug development, disease modelling, neurotoxicity assessment, compound screening, target validation and translational research.

Cookie bar

We use cookies and other tracking technologies to improve your experience and analyse our website traffic.

Please consult our Privacy Policy for more information.

By clicking on “Accept”, you consent to your data being collected

You can change your cookie settings and disable cookies, except for essential functional ones, at any time.


Functional
Preference
Statistical
Marketing